Gavrilin Mikhail A, Mitra Srabani, Seshadri Sudarshan, Nateri Jyotsna, Berhe Freweine, Hall Mark W, Wewers Mark D
Division of Pulmonary Allergy Critical Care and Sleep Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH 43210, USA.
J Immunol. 2009 Jun 15;182(12):7982-9. doi: 10.4049/jimmunol.0803073.
Relative to monocytes, human macrophages are deficient in their ability to process and release IL-1beta. In an effort to explain this difference, we used a model of IL-1beta processing and release that is dependent upon bacterial escape into the cytosol. Fresh human blood monocytes were compared with monocyte-derived macrophages (MDM) for their IL-1beta release in response to challenge with Francisella novicida. Although both cell types produced similar levels of IL-1beta mRNA and intracellular pro-IL-1beta, only monocytes readily released processed mature IL-1beta. Baseline mRNA expression profiling of candidate genes revealed a remarkable deficiency in the pyrin gene, MEFV, expression in MDM compared with monocytes. Immunoblots confirmed a corresponding deficit in MDM pyrin protein. To determine whether pyrin levels were responsible for the monocyte/MDM difference in mature IL-1beta release, pyrin expression was knocked down by nucleofecting small interfering RNA against pyrin into monocytes or stably transducing small interfering RNA against pyrin into the monocyte cell line, THP-1. Pyrin knockdown was associated with a significant drop in IL-1beta release in both cell types. Importantly, M-CSF treatment of MDM restored pyrin levels and IL-1beta release. Similarly, the stable expression of pyrin in PMA-stimulated THP-1-derived macrophages induces caspase-1 activation, associated with increased IL-1beta release after infection with F. novicida. In summary, intracellular pyrin levels positively regulate MDM IL-1beta responsiveness to Francisella challenge.
相对于单核细胞,人类巨噬细胞在加工和释放白细胞介素-1β(IL-1β)的能力上存在缺陷。为了解释这种差异,我们使用了一种依赖细菌逃避免疫进入胞质溶胶的IL-1β加工和释放模型。将新鲜的人类血液单核细胞与单核细胞衍生的巨噬细胞(MDM)进行比较,观察它们在受到新凶手弗朗西斯菌攻击后IL-1β的释放情况。尽管两种细胞类型产生的IL-1β信使核糖核酸(mRNA)水平和细胞内前体IL-1β相似,但只有单核细胞能轻易释放加工后的成熟IL-1β。对候选基因的基线mRNA表达谱分析显示,与单核细胞相比,MDM中吡啉基因(MEFV)的表达明显不足。免疫印迹证实MDM中吡啉蛋白相应缺乏。为了确定吡啉水平是否是单核细胞/MDM在成熟IL-1β释放上存在差异的原因,通过将针对吡啉的小干扰RNA核转染到单核细胞中,或将针对吡啉的小干扰RNA稳定转导到单核细胞系THP-1中,敲低吡啉的表达。吡啉敲低与两种细胞类型中IL-1β释放的显著下降相关。重要的是,用巨噬细胞集落刺激因子(M-CSF)处理MDM可恢复吡啉水平和IL-1β释放。同样,在佛波酯(PMA)刺激的THP-1衍生巨噬细胞中稳定表达吡啉可诱导半胱天冬酶-1激活,这与感染新凶手弗朗西斯菌后IL-1β释放增加有关。总之,细胞内吡啉水平正向调节MDM对新凶手弗朗西斯菌攻击的IL-1β反应性。